iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
75 hedge funds and large institutions have $46.2M invested in iShares Genomics Immunology and Healthcare ETF in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
46% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 24
Holders
75
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.58M | |
| 2 | +$1.43M | |
| 3 | +$1.06M | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$1.02M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$573K |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$785K | |
| 3 | -$588K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$540K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$429K |